Logo image
A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI
Journal article   Peer reviewed

A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRI

Terumi Murakami, Yukiko K Hayashi, Megumu Ogawa, Satoru Noguchi, Kevin P Campbell, Masami Togawa, Takehiko Inoue, Akira Oka, Kousaku Ohno, Ikuya Nonaka, …
Brain & development (Tokyo. 1979), Vol.31(6), pp.465-468
2009
DOI: 10.1016/j.braindev.2008.08.005
PMCID: PMC2702532
PMID: 18804929
url
http://doi.org/10.1016/j.braindev.2008.08.005View
Open Access

Abstract

We report a patient harboring a novel homozygous mutation of c.604T > G (p.F202V) in POMT2. He showed delayed psychomotor development but acquired the ability to walk at the age of 3 years and 10 months. His brain MRI was normal. No ocular abnormalities were seen. Biopsied skeletal muscle revealed markedly decreased but still detectable glycosylated forms of alpha-dystroglycan (α-DG). Our results indicate that mutations in POMT2 can cause a wide spectrum of clinical phenotypes as observed in other genes associated with α-dystroglycanopathy. Presence of small amounts of partly glycosylated α-DG may have a role in reducing the clinical symptoms of α-dystroglycanopathy.
POMT2 Limb girdle muscular dystrophy Brain MRI Congenital muscular dystrophy α-Dystroglycan α-Dystroglycanopathy

Details

Metrics

Logo image